{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:26:28Z","timestamp":1785338788347,"version":"3.55.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01477","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T04:37:21Z","timestamp":1561523841000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review"],"prefix":"10.3389","volume":"10","author":[{"given":"Gareth","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles F. H.","family":"Diercks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A. J.","family":"Seelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn B. A.","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Damman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fmed.2018.00220","article-title":"The growing incidence of bullous pemphigoid: overview and potential explanations","volume":"5","author":"Kridin","year":"2018","journal-title":"Front Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3389\/fimmu.2018.00639","article-title":"Complement activation in inflammatory skin diseases","volume":"9","author":"Giang","year":"2018","journal-title":"Front Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/1523-1747.ep12259679","article-title":"Deposition of the membrane attack complex of complement in bullous pemphigoid","volume":"82","author":"Dahl","year":"1984","journal-title":"J Investig Dermatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1172\/JCI107288","article-title":"The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids","volume":"52","author":"Jordon","year":"1973","journal-title":"J Clin Investig"},{"key":"B5","doi-asserted-by":"publisher","first-page":"72s","DOI":"10.1111\/1523-1747.ep12275497","article-title":"Immunopathologic mechanisms in pemphigus and bullous pemphigoid","volume":"85","author":"Jordon","year":"1985","journal-title":"J Investig Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1600-0560.2008.01129.x","article-title":"C4d immunohistochemical stain is a sensitive method to confirm immunoreactant deposition in formalin-fixed paraffin-embedded tissue in bullous pemphigoid","volume":"36","author":"Chandler","year":"2009","journal-title":"J Cutan Pathol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1097\/DAD.0000000000000943","article-title":"Bullous pemphigoid: use of C4d immunofluorescent staining in a case with repeated negative conventional direct immunofluorescence studies","volume":"39","author":"Kassaby","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jaad.2008.06.022","article-title":"The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease","volume":"59","author":"Magro","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1600-0560.2009.01450.x","article-title":"C3d immunohistochemistry on formalin-fixed tissue is a valuable tool in the diagnosis of bullous pemphigoid of the skin","volume":"37","author":"Pfaltz","year":"2010","journal-title":"J Cutan Pathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/DAD.0000000000000333","article-title":"Application of C4d immunohistochemistry on routinely processed tissue sections for the diagnosis of autoimmune bullous dermatoses","volume":"38","author":"Villani","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1172\/JCI117826","article-title":"The role of complement in experimental bullous pemphigoid","volume":"95","author":"Liu","year":"1995","journal-title":"J Clin Investig"},{"key":"B12","doi-asserted-by":"publisher","first-page":"15003","DOI":"10.1074\/jbc.M111.221036","article-title":"The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid","volume":"286","author":"Heimbach","year":"2011","journal-title":"J Biol Chem"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1172\/JCI17891","article-title":"Role of different pathways of the complement cascade in experimental bullous pemphigoid","volume":"116","author":"Nelson","year":"2006","journal-title":"J Clin Investig"},{"key":"B14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nm1496","article-title":"Humanization of autoantigen","volume":"13","author":"Nishie","year":"2007","journal-title":"Nat Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Liu","year":"2008","journal-title":"J Autoimmun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"7746","DOI":"10.4049\/jimmunol.1000667","article-title":"Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model","volume":"185","author":"Li","year":"2010","journal-title":"J Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fimmu.2018.00488","article-title":"Tissue destruction in bullous pemphigoid can be complement independent and may be mitigated by C5aR2","volume":"9","author":"Karsten","year":"2018","journal-title":"Front Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.4049\/jimmunol.1003402","article-title":"Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner","volume":"188","author":"Natsuga","year":"2012","journal-title":"J Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.4049\/jimmunol.1400095","article-title":"Bullous pemphigoid autoantibodies directly induce blister formation without complement activation","volume":"193","author":"Ujiie","year":"2014","journal-title":"J Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.ajpath.2012.11.029","article-title":"Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway","volume":"182","author":"Hiroyasu","year":"2013","journal-title":"Am J Pathol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/jid.2008.305","article-title":"IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment","volume":"129","author":"Iwata","year":"2009","journal-title":"J Invest Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.imlet.2012.01.006","article-title":"Why human pemphigoid autoantibodies do not trigger disease by the passive transfer into mice?","volume":"143","author":"Sesarman","year":"2012","journal-title":"Immunol Lett."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1172\/JCI119639","article-title":"A major role for neutrophils in experimental bullous pemphigoid","volume":"100","author":"Liu","year":"1997","journal-title":"J Clin Investig"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1172\/JCI11494","article-title":"Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid","volume":"108","author":"Chen","year":"2001","journal-title":"J Clin Investig"},{"key":"B25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/bjd.14822","article-title":"Complement in bullous pemphigoid: results from a large observational study","volume":"176","author":"Romeijn","year":"2017","journal-title":"Br J Dermatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3389\/fimmu.2018.02687","article-title":"Complement-activating capacity of autoantibodies correlates with disease activity in bullous pemphigoid patients","volume":"9","author":"Chiorean","year":"2018","journal-title":"Front Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1001\/archderm.109.2.195","article-title":"Immunofluorescent studies in mucous membrane pemphigoid","volume":"109","author":"Griffith","year":"1974","journal-title":"Arch Dermatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/1523-1747.ep12485162","article-title":"Immunopathology of cicatricial pemphigoid: studies of complement deposition","volume":"68","author":"Rogers","year":"1977","journal-title":"J Investig Dermatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.jid.2017.03.037","article-title":"Experimental laminin 332 mucous membrane pemphigoid critically involves C5aR1 and reflects clinical and immunopathological characteristics of the human disease","volume":"137","author":"Heppe","year":"2017","journal-title":"J Investig Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1172\/JCI118942","article-title":"Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice","volume":"98","author":"Lazarova","year":"1996","journal-title":"J Clin Investig"},{"key":"B31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1006\/clim.2000.4845","article-title":"Fab fragments directed against laminin 5 induce subepidermal blisters in neonatal mice","volume":"95","author":"Lazarova","year":"2000","journal-title":"Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3349\/ymj.1998.39.4.339","article-title":"Complement-fixing abilities and IgG subclasses of autoantibodies in epidermolysis bullosa acquisita","volume":"39","author":"Cho","year":"1998","journal-title":"Yonsei Med J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/archderm.1992.01680110068008","article-title":"Studies on complement deposits in epidermolysis bullosa acquisita and bullous pemphigoid","volume":"128","author":"Mooney","year":"1992","journal-title":"Arch Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/sj.jid.5700254","article-title":"Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients","volume":"126","author":"Woodley","year":"2006","journal-title":"J Invest Dermatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.4049\/jimmunol.177.5.3461","article-title":"Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice","volume":"177","author":"Sitaru","year":"2006","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1172\/JCI200521386","article-title":"Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen","volume":"115","author":"Sitaru","year":"2005","journal-title":"J Clin Investig"},{"key":"B37","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3389\/fimmu.2018.00535","article-title":"Specific inhibition of complement activation significantly ameliorates autoimmune blistering disease in mice","volume":"9","author":"Mihai","year":"2018","journal-title":"Front Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"6514","DOI":"10.4049\/jimmunol.178.10.6514","article-title":"The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita","volume":"178","author":"Mihai","year":"2007","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/nm.2862","article-title":"Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1","volume":"18","author":"Karsten","year":"2012","journal-title":"Nat Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/imr.12337","article-title":"The era of the immunoglobulin A Fc receptor FcalphaRI; its function and potential as target in disease","volume":"268","author":"Aleyd","year":"2015","journal-title":"Immunol Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.4049\/jimmunol.1101763","article-title":"Blocking Fcalpha receptor I on granulocytes prevents tissue damage induced by IgA autoantibodies","volume":"189","author":"van der Steen","year":"2012","journal-title":"J Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1365-4362.1985.tb05575.x","article-title":"Linear IgA bullous dermatosis. An immunologically defined disease","volume":"24","author":"Wilson","year":"1985","journal-title":"Int J Dermatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4103\/0019-5154.80406","article-title":"Linear IgA bullous dermatosis in tunisian children: 31 cases","volume":"56","author":"Monia","year":"2011","journal-title":"Indian J Dermatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/eji.1830170304","article-title":"Activation of the alternative pathway of complement by human serum IgA","volume":"17","author":"Hiemstra","year":"1987","journal-title":"Eur J Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.4049\/jimmunol.167.5.2861","article-title":"Human IgA activates the complement system via the mannan-binding lectin pathway","volume":"167","author":"Roos","year":"2001","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.imbio.2006.01.003","article-title":"Lectin complement system and pattern recognition","volume":"211","author":"Endo","year":"2006","journal-title":"Immunobiology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1681\/ASN.2005090923","article-title":"Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease","volume":"17","author":"Roos","year":"2006","journal-title":"J Am Soc Nephrol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0140-6736(73)93006-7","article-title":"Alternate-pathway complement fixation by IgA in the skin in dermatitis herpetiformis","volume":"2","author":"Seah","year":"1973","journal-title":"Lancet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1172\/JCI107359","article-title":"Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid","volume":"52","author":"Provost","year":"1973","journal-title":"J Clin Invest."},{"key":"B50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1468-3083.2004.01132.x","article-title":"Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis","volume":"19","author":"Preisz","year":"2005","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00403-011-1132-1","article-title":"Mannan-binding lectin and ficolin deposition in skin lesions of pemphigus","volume":"303","author":"de","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/1523-1747.ep12680098","article-title":"Classical and alternate pathway activation of complement in pemphigus vulgaris lesions","volume":"63","author":"Jordon","year":"1974","journal-title":"J Investig Dermatol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/1523-1747.ep12709624","article-title":"Deposition of the membrane attack complex of complement in pemphigus vulgaris and pemphigus foliaceus skin","volume":"92","author":"Kawana","year":"1989","journal-title":"J Investig Dermatol"},{"key":"B54","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.4049\/jimmunol.137.9.2835","article-title":"Defining the role of complement in experimental pemphigus vulgaris in mice","volume":"137","author":"Anhalt","year":"1986","journal-title":"J Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jid.2017.08.030","article-title":"The anti-C1s antibody TNT003 prevents complement activation in the skin induced by bullous pemphigoid autoantibodies","volume":"138","author":"Kasprick","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1097\/TP.0000000000001804","article-title":"Blockade of HLA antibody-triggered classical complement activation in sera from subjects dosed with the anti-C1s monoclonal antibody TNT009-results from a randomized first-in-human phase 1 trial","volume":"101","author":"Muhlbacher","year":"2017","journal-title":"Transplantation"},{"key":"B57","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/cpt.1111","article-title":"A randomized, first-in-human, healthy volunteer trial of sutimlimab, a humanized antibody for the specific inhibition of the classical complement pathway","volume":"104","author":"Bartko","year":"2018","journal-title":"Clin Pharmacol Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1111\/ajt.14426","article-title":"High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine","volume":"17","author":"McNamara","year":"2017","journal-title":"Am J Transplant"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1681\/ASN.2016111179","article-title":"Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis","volume":"28","author":"Jayne","year":"2017","journal-title":"J Am Soc Nephrol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01477\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T19:25:04Z","timestamp":1694978704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01477\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,26]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2019.01477"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01477","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,26]]},"article-number":"1477"}}